Cite
HARVARD Citation
Azevedo, A. et al. (2017). BCR-ABL V280G Mutation, Potential Role in Imatinib Resistance: First Case Report. Clinical medicine insights. Oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Azevedo, A. et al. (2017). BCR-ABL V280G Mutation, Potential Role in Imatinib Resistance: First Case Report. Clinical medicine insights. Oncology. p. . [Online].